Home › U.S. Food and Drug Administration Approves POMALYST (pomalidomide)...
 

Keywords :   


U.S. Food and Drug Administration Approves POMALYST (pomalidomide)...

2013-02-09 07:14:10| Biotech - Topix.net

Celgene Corporation today announced the U.S. Food and Drug Administration has approved POMALYSTA brand therapy for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Tags: food administration drug drug administration

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Customers of failed crypto firm FTX set for refunds
07.10Hurricane Milton Graphics
07.10Hurricane Milton Storm Surge Watch/Warning Map
07.10Hurricane Milton Forecast Advisory Number 11
07.10Hurricane Leslie Graphics
07.10Hurricane Leslie Wind Speed Probabilities Number 22
07.10Hurricane Leslie Public Advisory Number 22
More »